Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Pinellia cough syrup (Banxia Zhike Tangjiang) is an approved traditional Chinese medicine (TCM) syrup developed and manufactured by Guizhou Yibai Pharmaceutical and its subsidiary Guizhou Yibai Women's Pharmacy. The formulation contains several herbal ingredients, including ginger-processed Pinellia, Ephedra, bitter apricot seed, Aster, coltsfoot, Trichosanthes peel, tangerine peel, and licorice. It is indicated for the treatment of wind-cold coughs, characterized by abundant phlegm, cough, and qi reversal. The syrup works by resolving phlegm, suppressing cough, and facilitating the smooth flow of lung qi.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Pinellia cough syrup.